Company / Depreciation & Amortization
Phio Pharmaceuticals Corp. Depreciation & Amortization History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$67.0K
FY2020
5-year range
$53.0K / $81.0K
FY2016-FY2020
Trend
-17.3%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $70,000 to $67,000 over the past 2 years.
Based on SEC 10-K filings.
$67,000 in FY2020 with a 3-year CAGR of +8.1%.
Improved from $70,000 to $67,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +8.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +8.1%, indicating consistent growth.
- In FY2020, depreciation & amortization decreased 17.3% year-over-year.
- Peak depreciation & amortization was recorded in FY2013.
- Lowest depreciation & amortization in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $67.0K | -17.3% |
| FY2019 | $81.0K | +15.7% |
| FY2018 | $70.0K | +32.1% |
| FY2017 | $53.0K | -31.2% |
| FY2016 | $77.0K | -47.6% |
| FY2013 | $147.0K | +0.0% |
| FY2012 | $147.0K | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026